Cerebricon Releases Model for Spinal Cord Injury
30 June 2005
Kuopio, Finland
June 21st, 2005
Cerebricon Ltd., a contract rersearch organization specializing in preclinical models of CNS disease, announces the release of a new model for the study of pharmaceutical candidates aimed at treating spinal cord injury.
The model, based on a T10 contusion, has both a basic histological end point package and a more comprehensive functional, behavioral and MRI battery if required.
The SCI model has been fully validated by CerebrÃcon's scientists in Cerebricon's proprietal laboratories.
